Vanguard Health Care Inv (VGHCX)

218.49 -1.12  -0.51% Aug 10 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 218.49
Turnover Ratio 18.00%
1 Year Fund Level Flows -4.547B

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 3.61% 2.71% 40
3M 7.81% 9.31% 64
6M 4.17% 6.96% 65
YTD 7.94% 9.25% 54
1Y 23.92% 23.39% 34
3Y 12.05% 13.53% 70
5Y 7.24% 6.98% 47
10Y 15.36% 15.84% 63
15Y 11.23% 11.13% 48
20Y 10.55% 9.22% 28
As of Aug. 10, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 2.69% 2.73% 0.04%
Stock 97.31% 97.31% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of June 30, 2020

Region Exposure

Americas 67.81%
North America 67.77%
Latin America 0.05%
Greater Europe 19.56%
United Kingdom 8.23%
Europe Developed 11.34%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 12.62%
Japan 11.21%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 1.42%
Market Classification
% Developed Markets 98.54%
% Emerging Markets 1.46%
As of June 30, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.85%
Industrials 0.00%
Real Estate 0.15%
Technology 0.00%
Utilities 0.00%
As of June 30, 2020

Stock Market Capitalization

Giant 46.31%
Large 35.75%
Medium 14.90%
Small 3.05%
Micro 0.00%
As of June 30, 2020

Stock Style Exposure

Large Cap Value 19.29%
Large Cap Blend 43.33%
Large Cap Growth 19.79%
Mid Cap Value 1.77%
Mid Cap Blend 4.75%
Mid Cap Growth 8.30%
Small Cap Value 0.38%
Small Cap Blend 0.58%
Small Cap Growth 1.81%
As of June 30, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
UNH UnitedHealth Group Inc 5.66% 315.75 -1.05%
AZN AstraZeneca PLC 5.37% -- --
PFE Pfizer Inc 4.99% 37.80 -1.54%
BMY Bristol-Myers Squibb Company 4.37% 63.20 +2.23%
NOVN Novartis AG 3.66% -- --
LLY Eli Lilly and Co 3.65% 151.48 -0.99%
REGN Regeneron Pharmaceuticals Inc 3.37% 598.85 -1.54%
4523 Eisai Co Ltd 3.10% -- --
ABT Abbott Laboratories 2.89% 99.39 -0.65%
BSX Boston Scientific Corp 2.72% 39.31 +0.85%
As of June 30, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks long-term capital appreciation. The fund invests at least 80% of its assets in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry. These companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities. It may also consider companies engaged in medical, diagnostic, biochemical, and other research and development activities. The fund may invest up to 50% of its assets in foreign stocks.
General
Security Type Mutual Fund
Oldest Share Symbol VGHCX
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name Vanguard
Benchmark Index
MSCI ACWI/Health Care NR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Jean Hynes 12.18 yrs

Share Classes

Symbol Share Class
VGHAX Inst

Net Fund Flows

1M -273.48M
3M -580.71M
6M -1.826B
YTD -2.253B
1Y -4.547B
3Y -12.32B
5Y -19.00B
10Y -17.33B
As of July 31, 2020

Risk Info

Beta (5Y) 0.8234
Historical Sharpe Ratio (10Y) 1.120
Historical Sortino (All) 1.347
Daily Value at Risk (VaR) 1% (All) 2.59%
Monthly Value at Risk (VaR) 1% (All) 10.58%

Fundamentals

Dividend Yield TTM (8-10-20) 1.11%
30-Day SEC Yield (8-6-20) 0.96%
7-Day SEC Yield --
Weighted Average PE Ratio 24.52
Weighted Average Price to Sales Ratio 2.318
Weighted Average Price to Book Ratio 3.788
Weighted Median ROE 14.07%
Weighted Median ROA 4.83%
Forecasted Dividend Yield 1.39%
Forecasted PE Ratio 18.16
Forecasted Price to Sales Ratio 2.239
Forecasted Price to Book Ratio 3.798
Number of Holdings 104
As of June 30, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.80%
Forecasted Book Value Growth 3.41%
Forecasted Cash Flow Growth 7.40%
Forecasted Earnings Growth 13.62%
Forecasted Revenue Growth 8.31%
As of June 30, 2020

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 3000.00 USD
Minimum Subsequent Investment 0.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.30%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 5/23/1984
Termination Date
Last Annual Report Date 1/31/2020
Last Prospectus Date 5/29/2020
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.